✦ LIBER ✦

Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Results From the OASIS-5 Trial

✍ Scribed by Shamir R. Mehta; Christopher B. Granger; John W. Eikelboom; Jean-Pierre Bassand; Lars Wallentin; David P. Faxon; Ron J.G. Peters; Andrzej Budaj; Rizwan Afzal; Susan Chrolavicius; Keith A.A. Fox; Salim Yusuf

Book ID: 119266962
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 609 KB
Volume: 50
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2007.07.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Fondaparinux Vers

Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines: Results From the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) Trial

✍ Sanjit S. Jolly; David P. Faxon; Keith A.A. Fox; Rizwan Afzal; William E. Boden; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 847 KB

Comparison of efficacy and safety of nat

Comparison of efficacy and safety of native eptifibatide vs. tirofiban in patients with acute coronary syndrome undergoing percutaneous coronary intervention

✍ Jianjin Tang; Liansheng Wang; Hui Wang; Mingwei Wang; Kejiang Cao; Zhijian Yang 📂 Article 📅 2008 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 132 KB

Fondaparinux with UnfracTionated heparin

Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux

✍ Philippe Gabriel Steg; Shamir Mehta; Sanjit Jolly; Denis Xavier; Hans-Juergen Ru 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Safety and Efficacy of Bivalirudin With

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

✍ Harvey D. White; E. Magnus Ohman; A. Michael Lincoff; Michel E. Bertrand; Antoni 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 571 KB

Atorvastatin Pretreatment Improves Outco

Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention: Results of the ARMYDA-ACS Randomized Trial

✍ Giuseppe Patti; Vincenzo Pasceri; Giuseppe Colonna; Marco Miglionico; Dionigi Fi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Bivalirudin in patients with acute coron

Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial

✍ Gregg W Stone; Harvey D White; E Magnus Ohman; Michel E Bertrand; A Michael Linc 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 301 KB